Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Potratz

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Successful Extracorporeal Life Support in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Periengraftment Respiratory FailureJenny Potratz, Martina Ahlmann, Claudia Rössig, et al.
Cell Communication and Signaling : CCS|May 20, 2018
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signalingPhilipp Berning, Christiane Schaefer, Dagmar Clemens, et al.
Anti-Cancer Drugs|August 5, 2016
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell linesAleksandra Pettke, Marc Hotfilder, Dagmar Clemens, et al.
Plos One|February 1, 2018
Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithmChristiane Schaefer, Nikhil Mallela, Jochen Seggewiß, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 29, 2025
Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse eventLucas Weschle, Jenny Potratz, Frank Rutsch, et al.
Oral Oncology|May 1, 2007
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study groupSven Jasnau, Ulrich Meyer, Jenny Potratz, et al.
Klinische Padiatrie|September 26, 2023
[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)]Arne Simon, Thomas Lehrnbecher, Yeliz Baltaci, et al.
Intensive Care Medicine|August 25, 2019
Research priorities in pediatric onco-critical care: an international Delphi consensus studyMarijn Soeteman, Jenny Potratz, Jeppe S Angaard Nielsen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Successful Extracorporeal Life Support in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Periengraftment Respiratory FailureJenny Potratz, Martina Ahlmann, Claudia Rössig, et al.
Cell Communication and Signaling : CCS|May 20, 2018
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signalingPhilipp Berning, Christiane Schaefer, Dagmar Clemens, et al.
Anti-Cancer Drugs|August 5, 2016
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell linesAleksandra Pettke, Marc Hotfilder, Dagmar Clemens, et al.
Plos One|February 1, 2018
Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithmChristiane Schaefer, Nikhil Mallela, Jochen Seggewiß, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 29, 2025
Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse eventLucas Weschle, Jenny Potratz, Frank Rutsch, et al.
Oral Oncology|May 1, 2007
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study groupSven Jasnau, Ulrich Meyer, Jenny Potratz, et al.
Klinische Padiatrie|September 26, 2023
[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)]Arne Simon, Thomas Lehrnbecher, Yeliz Baltaci, et al.
Intensive Care Medicine|August 25, 2019
Research priorities in pediatric onco-critical care: an international Delphi consensus studyMarijn Soeteman, Jenny Potratz, Jeppe S Angaard Nielsen, et al.
Pageof 3